4//SEC Filing
Freed Martin I 4
Accession 0001209191-20-037560
CIK 0001707502other
Filed
Jun 17, 8:00 PM ET
Accepted
Jun 18, 4:10 PM ET
Size
8.3 KB
Accession
0001209191-20-037560
Insider Transaction Report
Form 4
Freed Martin I
Director
Transactions
- Award
Director Stock Option (Right to Buy)
2020-06-16+30,000→ 30,000 totalExercise: $3.03Exp: 2030-06-16→ Common Stock (30,000 underlying) - Award
Director Stock Option (Right to Buy)
2020-06-16+10,000→ 10,000 totalExercise: $3.03Exp: 2030-06-16→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This option was granted on June 16, 2020 and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
- [F2]This option was granted on June 16, 2020 to members of the Clinical Committee of the Board of Directors and vests in full on the earlier to occur of the one-year anniversary of the grant date and immediately prior to the Issuer's next annual meeting of stockholders occurring after the grant date, and will vest automatically as to 100% of the unvested portion of such option upon specified change in control events.
Documents
Issuer
Solid Biosciences Inc.
CIK 0001707502
Entity typeother
Related Parties
1- filerCIK 0001676653
Filing Metadata
- Form type
- 4
- Filed
- Jun 17, 8:00 PM ET
- Accepted
- Jun 18, 4:10 PM ET
- Size
- 8.3 KB